Wendy Galbraith, Pharm.D., FAPhA, BCNP

Clinical Associate Professor

Pharmaceutical Sciences

Phone (405) 271-6481 x47195

Alt Phone x47187 (lab)

Fax (405) 271-7505

Office CPB 337

Email wendy-galbraith@ouhsc.edu

Summary

Clinical Expertise: NuclearPharmacy and Radiopharmaceuticals. Development and growth of professional education in nuclear pharmacy. This includes overseeing all professional education in nuclear pharmacy including elective/selective course work in the doctor of pharmacy program (including Pharm.D./M.S.), pharmacy interns employed in the nuclear pharmacy, continuing professional education for nuclear pharmacists, board certification for nuclear pharmacists employed in the nuclear pharmacy, residency program in nuclear pharmacy, and nuclear pharmacy education for other health care professionals including but not limited to nuclear medicine technologists, nuclear medicine and radiology residents, and health physicists.


Certifications & Licenses

Board Certified Nuclear Pharmacist

Board of Pharmaceutical Specialties

1996

Registered Pharmacist

State of Arizona

1990

Registered Pharmacist

State of Oklahoma

1993

Publications & Presentations

1 2 3 4 > >>
    1. Galbraith W. Considerations for the Safe Handling of Radiolabeled Blood Products . American Pharmacist Association Press, . 2020; 2020 : 85-132

    2. Galbraith W. Kidney. American Pharmacist Association Press, . 2020; 2020 : 705-748

    3. Galbraith W. Liver, Spleen, and Gastrointestinal Systems. American Pharmacist Association Press, . 2020; 2020 : 705-748

    4. Wolfe K, Baldwin J D, Grantham V V, Galbraith W. Y-90-Labeled Resin Microsphere Spills: A Pilot Study to Determine Efficient Cleanup Practices. JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY. 2020; 48 : 274-277

    5. Wolfe K, Baldwin J, Grantham V V, Galbraith W. 90Y-Labeled Resin Microsphere Spills: A Pilot Study to Determine Efficient Cleanup Practices. Journal of nuclear medicine technology. 2020; 48 : 274-277

1 2 3 4 > >>



Grants

    1. Imaging and Blood Biomarkers to Predict Graft Failure after HSCT. Multi-institutional Prospective Pilot Research of Imaging and blood biomarker EValuation of Engraftment after ALlogeneic Hematopoietic Stem Cell Transplantation in Children and Adults (REVEAL). . NIH. End Date: 2024.

    2. Dose-escalation Study of Radio-labeled Antibody, FF-21101(90Y), P-Cadherin, for the Treatment of Advanced Cancer.. Misc Non-Federal. Start Date: 2019.

    3. Residual blood, mold, and infectious contamination in nuclear pharmacy dose containers following a common disinfection method. Misc Non-Federal. Start Date: 2016. End Date: 2017.




Awards and Honors

                                                                                            1. APhA-APPM.  APhA-APPM Contributed Paper Merit Award: Evaluation of a compact automated system for filling syringes in a nuclear pharmacy. Date: 2019.  

                                                                                            2. College of Pharmacy Allumni. E. Blanche Sommers Award. Date: 2006.  




                                                                                  
                        
                        
                      
                  
 
                
     
                
                 	                                        
                    
                                            	                           
                                                
                                                                                                                      
Education
                           
                        
                                                                                            1.  Degree: PharmD. University of Oklahoma Health Sciences Center . Date: 2003.  

                                                                                            2.  Degree: B. Pharm. University of Oklahoma Health Sciences Center. Date: 1990.